CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will webcast its upcoming R&D Day live on the Investors section of the company’s website, www.alnylam.com the morning of December 10, 2015.
Alnylam management and leading physicians will discuss development candidates from the company’s RNAi therapeutics pipeline. The event will include presentations from the following guest speakers:
